2013-05-13-Bain-India_Private_Equity_Report_2013_48页_5mb

报告摘要

India Private Equity Report 2013 Summary

2012 Highlights: India's private equity deal value dropped from $14.8 billion in 2011 to $10.2 billion in 2012, despite a slight increase in the number of deals (531 to 551). Average deal size fell significantly, driven by market caution amid political and economic uncertainty. Healthcare emerged as a standout sector, with investments tripling to nearly $1.3 billion.
Fundraising Challenges: Limited partner caution led to reduced allocations, with only $3.5 billion committed in 2012 compared to $6.8 billion in 2011. Fundraising remains steady but cautious, with overseas investors dominating sources.
Deal Trends: Early-stage and venture capital saw growth, with many small deals under $10 million. Economic uncertainty shrank deal sizes, but healthcare and IT sectors showed resilience.
Exit Opportunities: Exits increased to 115 deals in 2012, valued at $6.8 billion, with public market sales being the primary route. Secondary transactions and strategic sales gained prominence.
Healthcare Focus: Healthcare investments nearly tripled in 2012, accounting for 12% of total deal value. Driven by factors like rising population, increased affordability, and government schemes, it remains a recession-proof growth area.

Fundraising: A decline in LP allocations (down to $3.5B) and regulatory uncertainties pressured fundraising. GPs emphasize differentiated strategies and track records to attract capital.
Deal Making: Conservative deal activity persists due to market caution. Sector-wise, healthcare and IT/ITES lead investments, while infrastructure and real estate lag due to economic challenges. Deal sizes are shrinking except for high-value investments in healthcare.
Portfolio Management: PE investors now focus more holistically on value addition, including operational improvements and strategic guidance. Entrepreneurs are increasingly open to such support.
Exits: Exit volumes rose, with healthcare contributing significantly. GPs predict moderate growth in 2013, with exits likely increasing as capital markets stabilize, despite challenges from past economic headwinds.
Healthcare: Key growth drivers include demographic shifts, rising diseases (e.g., diabetes), and policy support. Investments are concentrated in delivery services and pharmaceuticals. High demand for specialized care and digital health innovations creates opportunities for new exits.

Growth Prospects: Despite setbacks, the medium term looks cautiously positive for India's PE sector. Fundraising and deal activity will improve as market maturity increases and regulations clarify.
Challenges: Mismatch in valuations, exit pressures, and LP selectivity remain key hurdles. GPs will need strong value-proven strategies and exits to remain competitive.
Recommendations:
- GPs: Focus on long-term relationships, holistic diligence, and value creation through operational expertise.
- Entrepreneurs: Embrace PE as a strategic partner, aligning expectations and exits early.
- LPs: Scrutinize GP exit records more closely given the growing unexited portfolio.
- Policy Makers: Address regulatory hurdles to enhance PE's role in economic growth and infrastructure financing.

Growth Metrics: India's healthcare market grows at 11–20% CAGR, worth $5 billion in 2012 and projected to reach $78 billion by 2020. Delivery services (60% of health spending) offer high margins, while pharmaceuticals and diagnostics see steady demand.
Investment Trends: Late-stage deals increased, with early-stage opportunities emerging. Interest from both domestic and global funds is strong, fueled by exit success stories. Private equity's expertise in scaling and operationalizing healthcare firms positions it as a key enabler.

This summary captures the strategic imperatives, sector dynamics, and key recommendations for stakeholders across India's evolving PE ecosystem.

展开完整摘要